Orion Corporation: Managers’ Transactions Update
Orion Corporation has received a disclosure under the Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.
Details of the Transaction
Name of person subject to notification: Niclas Lindstedt
Position: Other senior manager
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: Initial Notification
Reference number: 74920/9/8
Transaction Overview
Date of transaction: August 20, 2024
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: Share
ISIN: FI0009014377
Nature of transaction: Disposal
Transaction Details
1. Volume: 614, Unit price: 46.7 EUR
2. Volume: 521, Unit price: 46.7 EUR
3. Volume: 200, Unit price: 46.7 EUR
4. Volume: 200, Unit price: 46.7 EUR
5. Volume: 100, Unit price: 46.7 EUR
6. Volume: 125, Unit price: 46.7 EUR
7. Volume: 100, Unit price: 46.7 EUR
8. Volume: 125, Unit price: 46.7 EUR
9. Volume: 8, Unit price: 46.7 EUR
10. Volume: 5, Unit price: 46.7 EUR
11. Volume: 2, Unit price: 46.7 EUR
Aggregated transaction volume: 2000 Volume weighted average price: 46.7 EUR
About Orion Corporation
Orion is a globally operating Finnish pharmaceutical company dedicated to promoting well-being for over a century. The company develops, manufactures, and markets human and veterinary pharmaceuticals as well as active pharmaceutical ingredients. With an extensive portfolio of proprietary and generic medicines and consumer health products, Orion focuses its pharmaceutical R&D on core therapy areas including oncology and pain management. The proprietary products developed by Orion are utilized for the treatment of cancer, neurological diseases, and respiratory conditions, among others. In the last financial year, Orion reported net sales of EUR 1,190 million and employed approximately 3,600 individuals. The company's A and B shares are listed on Nasdaq Helsinki.
Frequently Asked Questions
What is the nature of the transaction disclosed?
The nature of the transaction is a disposal of shares by Niclas Lindstedt, a senior manager at Orion Corporation.
How many shares were disposed of?
A total of 2000 shares were disposed of at an average price of 46.7 EUR per share.
What is Orion Corporation known for?
Orion Corporation is known for developing, manufacturing, and marketing human and veterinary pharmaceuticals, focusing on oncology and pain management.
Where are Orion's shares listed?
Orion Corporation's A and B shares are listed on Nasdaq Helsinki.
What was Orion's net sales figure in 2023?
Orion's net sales amounted to EUR 1,190 million in the last financial year.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/